Post by Biogen

Name: We’re attending the American Transplant Congress (ATC) to share new data on our investigational ther
Uploaded: 2026-06-18T13:00:45.025Z
Channel: Biogen
Description: We’re attending the American Transplant Congress (ATC) to share new data on our investigational therapy designed to target CD-38 cells in antibody-mediated rejection (AMR) and microvascular inflammati

1,293,242 followers

We’re attending the American Transplant Congress (ATC) to share new data on our investigational therapy designed to target CD-38 cells in antibody-mediated rejection (AMR) and microvascular inflammation (MVI). Stop by booth #632 to learn more about our ongoing research and late-stage clinical trials for kidney transplant recipients diagnosed with AMR and MVI. Learn more: ow.ly/MNtN50ZcR2t

Video Content